Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma
The DOI matches its Crossref record; 17 of the 23 references it cites were found in a registry or an index.
Abstract
Background Interstitial fluid pressure (IFP) in rodent malignant tumors is reportedly much higher than in surrounding normal tissue. We hypothesized the same may be true in human invasive breast tumors. Methods We measured IFP in the operating room in 25 patients undergoing excision breast biopsy under local anesthetic for diagnostic purposes. Results In patients with invasive ductal carcinomas IFP was 29 +/- 3 (SE) mm Hg, compared with -0.3 +/- 0.1 mm Hg in those with normal breast parenchyma (p Conclusions IFP measurements may facilitate radiographic or ultrasound localization of small or nonpalpable malignant tumors in those patients undergoing needle aspiration cytology or stereotactic core needle biopsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated extracellular stresses have been observed in many tumors[170][171][172][173][174][175][176][177][178].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [177]
In the citing paper
“It enhances tumor cell proliferation and builds up a transport barrier to drug delivery, greatly lowering the efficacy of anticancer drugs and therapies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [177]
In the citing paper
“However, due to the pathologically elevated interstitial fluid pressure and dense extracellular matrix (ECM) in solid tumors, the transport of antitumor drugs in tumor tissues becomes difficult. 386 , 387 , 388”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [388]
Citations
Cites
Hahn, G. J., Draper, N., & Smith, H. (1982) · Technometrics · doi:10.2307/1267833 · Cited by 5,773
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972 · cited 2×
“Tumor cells secrete a permeability-enhancing factor ( 3 ), which further contributes to the high vascular permeability in ma lignant tumors.”
BackgroundFolkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Nonparametric Statistical Methods.
Moore, D. S., Hollander, M., & Wolfe, D. A. (1974) · Journal of the American Statistical Association · doi:10.2307/2285701 · Cited by 2,857
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00047468 · Cited by 866
(1990) · PubMed · Cited by 757
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
THE INTERSTITIAL FLUID OF SOLID TUMORS.
Gullino, P. M., Clark, S. H., & Grantham, F. H. (1964) · PubMed · Cited by 272
(1992) · PubMed · Cited by 252
Research works printed but not linked: 5
- 2._Peterson HI. The microcirculation of tumors. In: Orr FW, Buchanan MR, Weiss L, eds.Microcirculation in cancer metastases. Ann Arbor, MI: CRC Press, 1991:277–98.
- 15._Hollander M, Wolfe D. Distribution free rank sum test (Wilcoxon) and distribution free test (Kruskal-Wallis). In: Hollander M, Wolfe D, eds.Nonparametric statisticalmethods. New York: Wiley, 1973:68–74, 115-9.
- 17._Liotta LA, Stetler-Stevenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: Devita VT, Hellman S, Rosenberg SA, eds.Cancer: principles and practice ofoncology. 3rd ed. Philadelphia: J. B. Lippincott, 1989:98–115.
- 18._Sugarbaker EV. Patterns of metastasis in human malignancies.Cancer Biol Rev 1981;2:235–78.
- 20._Nathanson SD, Putnam M. Metastasis to regional lymph nodes: the influence of lymphatic flow rates.Clin and Exp Metastasis 1990;8:71–2.
Cited by
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044
“Furthermore, the excessive leakage of blood plasma from the abnormal vascular network in conjunction with the lack of functional lymphatic vessels to maintain fluid balance as well as the increased resistance to interstitial fluid flow due to low hydraulic conductivity result in interstitial hypertension (19, 21, 50,…”
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
“However, as a result of abnormal permeability, lymphatic vessel malfunction, interstitial fibrosis, contraction of interstitial tissues mediated by stromal fibroblasts [86], and compression from multiplying tumor cells [97], interstitial fluid pressure (IFP) in tumors is increased and can be up to 60 mmHg [86, 98-101].”
BackgroundNia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
“These are (i) elevated solid stress, (ii) elevated interstitial fluid pressure (IFP) and the resulting fluid flow in the interstitium, (iii) increased stiffness and altered material properties, and (iv) altered microarchitecture (Fig.”
BackgroundInfluentialDelivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Samani, A., Zubovits, J., & Plewes, D. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/6/002 · Cited by 707
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Jain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612
Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
Chidambaram, M., Manavalan, R., & Kathiresan, K. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j30c7d · Cited by 566
“on size, surface character, circulation half-life of the nanoparticles and the degree of angiogenesis of the tumor (24-26).”
BackgroundJain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Insights into the mechanisms of lymph node metastasis
Nathanson, S. D. (2003) · Cancer · doi:10.1002/cncr.11464 · Cited by 433
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 433
Yoshida, G. J. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01611-0 · Cited by 316
Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy
Gong, H., Chao, Y., Xiang, J., Han, X., Song, G., Feng, L., Liu, J., Yang, G., Chen, Q., & Liu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00068 · Cited by 322
The tumor microenvironment and metastatic disease
Lunt, S. J., Chaudary, N., & Hill, R. P. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9182-2 · Cited by 298
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
(2000) · PubMed · Cited by 295
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00027-6 · Cited by 271
Netti, P. A., Baxter, L. T., Boucher, Y., Skalak, R., & Jain, R. K. (1995) · PubMed · Cited by 263
Delivery of Molecular and Cellular Medicine to Solid Tumors
Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709148314 · Cited by 198
(2001) · PubMed · Cited by 257
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Integrin Signaling in Cancer Cell Survival and Chemoresistance
Aoudjit, F., & Vuori, K. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/283181 · Cited by 205
“This high interstitial fluid pressure is a major factor in the formation of tumor barrier to transcapillary transport [158], and has been shown to exist in several types of tumors such as breast and colorectal cancers [159, 160], metastatic melanoma [161, 162], and head and neck carcinoma [163].”
BackgroundLinking cell mechanical memory and cancer metastasis
Cambria, E., Coughlin, M. F., Floryan, M. A., Offeddu, G. S., Shelton, S. E., & Kamm, R. D. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00656-5 · Cited by 183
“IFP is uniform in the core of the tumour, varying between 2 mmHg (0.3 kPa) and 29 mmHg (3.9 kPa) 82–85 , and drops to normal values of about 0 mmHg (0 kPa) 84 at the tumour periphery or in the surrounding normal tissue 86 .”
InfluentialKharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-41 · Cited by 197
“Another feature of the pathophysiology of the tumor microenvironment, is elevated interstitial fluid pressure (IFP) ranging from 10 to 100 mmHg [98,99] while IFP of normal tissue is around zero [100].”
BackgroundInterstitial fluid pressure in intracranial tumours in patients and in rodents
Boucher, Y., Salehi, H., Witwer, B., Harsh, G., & Jain, R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.148 · Cited by 191
Intratumoral Drug Delivery with Nanoparticulate Carriers
Holback, H., & Yeo, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0360-y · Cited by 187
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00237-x · Cited by 186
Mechanical Forces in Tumor Angiogenesis
Zanotelli, M. R., & Reinhart-King, C. A. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-95294-9_6 · Cited by 153
Milosevic, M., Fyles, A., Hedley, D., & Hill, R. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.006 · Cited by 163
Rickard, B. P., Conrad, C., Sorrin, A. J., Ruhi, M. K., Reader, J. C., Huang, S. A., Franco, W., Scarcelli, G., Polacheck, W. J., Roque, D. M., et al. (2021) · Cancers · doi:10.3390/cancers13174318 · Cited by 183
Nanotechnology for breast cancer therapy
Tanaka, T., Decuzzi, P., Cristofanilli, M., Sakamoto, J. H., Tasciotti, E., Robertson, F. M., & Ferrari, M. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9209-0 · Cited by 181
Interstitial Stress and Fluid Pressure Within a Growing Tumor
Sarntinoranont, M., Rooney, F. J., & Mauro Ferrari, B. (2003) · Annals of Biomedical Engineering · doi:10.1114/1.1554923 · Cited by 150
Real-time Imaging of Tumor-Cell Shedding and Trafficking in Lymphatic Channels
Hayashi, K., Jiang, P., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., Moossa, A. R., Bouvet, M., & Hoffman, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1237 · Cited by 131
Yoshida, G. J., Azuma, A., Miura, Y., & Orimo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092256 · Cited by 126
Interstitial flow promotes macrophage polarization toward an M2 phenotype
Li, R., Serrano, J. C., Xing, H., Lee, T. A., Azizgolshani, H., Zaman, M., & Kamm, R. D. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-03-0164 · Cited by 125
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119
Wu, H., Chang, D.-K., & Huang, C.-T. (2006) · Cited by 185
Effect of heterogeneous vasculature on interstitial transport within a solid tumor
Zhao, J., Salmon, H. W., & Sarntinoranont, M. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.12.003 · Cited by 118
Lunt, S. J., Kalliomaki, T. M., Brown, A., Yang, V. X., Milosevic, M., & Hill, R. P. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-2 · Cited by 106
Hofmann, M., Guschel, M., Bernd, A., Bereiter-Hahn, J., Kaufmann, R., Tandi, C., Wiig, H., & Kippenberger, S. (2006) · Neoplasia · doi:10.1593/neo.05469 · Cited by 106
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment
Sorrin, A. J., Ruhi, M. K., Ferlic, N. A., Karimnia, V., Polacheck, W. J., Celli, J. P., Huang, H., & Rizvi, I. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13209 · Cited by 109
“Another study by Nathanson and colleagues measured the mean tumor IFP from ductal carcinoma patients as 29 mmHg (56).”
BackgroundPiotrowski-Daspit, A. S., Tien, J., & Nelson, C. M. (2016) · Integrative Biology · doi:10.1039/c5ib00282f · Cited by 101
Burack, R. C., Gimotty, P. A., George, J., McBride, S., Moncrease, A., Simon, M. S., Dews, P., & Coombs, J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12<2391::aid-cncr13>3.0.co;2-k · Cited by 59
Pishko, G. L., Astary, G. W., Mareci, T. H., & Sarntinoranont, M. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0349-7 · Cited by 96
NIR Spectroscopic Detection of Breast Cancer
Nioka, S., & Chance, B. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400504 · Cited by 106
Physiological and Pathological Factors of Human Breast Disease That Can Influence Optical Diagnosisa
Thomsen, S., & Tatman, D. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08197.x · Cited by 93
Near-Infrared Optical Mammography for Breast Cancer Detection with Intrinsic Contrast
Fantini, S., & Sassaroli, A. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0404-4 · Cited by 89
Kuszyk, B. S., Corl, F. M., Franano, F. N., Bluemke, D. A., Hofmann, L. V., Fortman, B. J., & Fishman, E. K. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.4.1770747 · Cited by 88
Böckelmann, L. C., & Schumacher, U. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702974 · Cited by 72
“Generally, a positive correlation with TIFP and tumor size was observed [63,69,70].”
Background1995 Whitaker lecture: Delivery of molecules, particles, and cells to solid tumors
Jain, R. K. (1996) · Annals of Biomedical Engineering · doi:10.1007/bf02648108 · Cited by 80
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Yun, W. S., Kim, J., Lim, D.-K., Kim, D.-H., Jeon, S. I., & Kim, K. (2023) · Nanomaterials · doi:10.3390/nano13152225 · Cited by 76
“intratumoral IFP is 2–20-fold higher than that of normal tissues [35,36].”
BackgroundTorosean, S., Flynn, B., Axelsson, J., Gunn, J., Samkoe, K. S., Hasan, T., Doyley, M. M., & Pogue, B. W. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.07.002 · Cited by 73
Seo, B. R., DelNero, P., & Fischbach, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.011 · Cited by 74
Haider, M. A., Milosevic, M., Fyles, A., Sitartchouk, I., Yeung, I. W. T., Henderson, E., Lockwood, G. A., Lee, T., & Roberts, T. P. L. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.12.064 · Cited by 74
Molecular mechanisms of metastasis
Hoon, D. S. �., Kitago, M., Kim, J., Mori, T., Piris, A., Masterpol, K. S., Mihm, M. C., Nathanson, S. D., Padera, T. P., Chambers, A. F., et al. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-8500-x · Cited by 69
Self-citationCarp, S. A., Kauffman, T., Fang, Q., Rafferty, E. A., Moore, R. H., Kopans, D. B., & Boas, D. A. (2006) · Journal of Biomedical Optics · doi:10.1117/1.2397572 · Cited by 68
A new paradigm for mechanobiological mechanisms in tumor metastasis
Torzilli, P. A., Bourne, J. W., Cigler, T., & Vincent, C. T. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.002 · Cited by 71
“Interstitial fluid pressures in tumors have also been found to increase with tumor size and vascularity [34, 35].”
BackgroundSentinel lymph node metastases in cancer: Causes, detection and their role in disease progression
Nathanson, S. D., Shah, R. A., & Rosso, K. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.10.002 · Cited by 69
Self-citationChallenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors
Paresishvili, T., & Kakabadze, Z. (2023) · Oncology Reviews · doi:10.3389/or.2023.10577 · Cited by 68
Lee, S. W. L., Seager, R. J., Litvak, F., Spill, F., Sieow, J. L., Leong, P. H., Kumar, D., Tan, A. S. M., Wong, S. C., Adriani, G., et al. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa007 · Cited by 60
von Mensdorff-Pouilly, S., Petrakou, E., Kenemans, P., van Uffelen, K., Verstraeten, A. A., Snijdewint, F. G. M., van Kamp, G. J., Schol, D. J., Reis, C. A., Price, M. R., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<702::aid-ijc16>3.0.co;2-1 · Cited by 137
Pathophysiology of Solid Tumors
Vaupel, P. W. (2009) · Medical radiology · doi:10.1007/978-3-540-74386-6_4 · Cited by 59
A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression
Norton, K., Wininger, M., Bhanot, G., Ganesan, S., Barnard, N., & Shinbrot, T. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.11.024 · Cited by 54
“Thus our results suggest that some attributes of the advancement of DCIS to IDC may be associated with biomechanical stresses, rather than being purely due to biochemical changes as is commonly assumed (Wiechmann and Kuerer, 2008).”
ResultInfluentialThe Mechanical Microenvironment in Breast Cancer
Pratt, S. J. P., Lee, R., & Martin, S. S. (2020) · Cancers · doi:10.3390/cancers12061452 · Cited by 57
“High IFP in breast cancer seems to be independent of tumor size [180,181], but correlated with tumor grade [181], however, one study reported opposite conclusions (correlations with size not grade) [182].”
BackgroundResultHaider, M. A., Sitartchouk, I., Roberts, T. P. L., Fyles, A., Hashmi, A.-T., & Milosevic, M. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20795 · Cited by 51
Modelling the transport of fluid through heterogeneous, whole tumours in silico
Sweeney, P. W., d’Esposito, A., Walker‐Samuel, S., & Shipley, R. J. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006751 · Cited by 54
Skliarenko, J. V., Lunt, S. J., Gordon, M. L., Vitkin, A., Milosevic, M., & Hill, R. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2046 · Cited by 51
Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs
van den Brand, D., Massuger, L. F., Brock, R., & Verdurmen, W. P. R. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00699 · Cited by 48
Moen, I., Tronstad, K. J., Kolmannskog, O., Salvesen, G. S., Reed, R. K., & Stuhr, L. E. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-446 · Cited by 49
“Solid tumors have a pathologically increased interstitial fluid pressure (Pif) and a dense ECM that make transport of chemotherapeutic agents difficult [3-7].”
BackgroundPrecision Hydrogels for the Study of Cancer Cell Mechanobiology
Sievers, J., Mahajan, V., Welzel, P. B., Werner, C., & Taubenberger, A. V. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202514 · Cited by 53
Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis.
Baronzio, G., Schwartz, L. H., Kiselevsky, M. V., Guais, A., Sanders, E., Milanesi, G., Baronzio, M., & Freitas, I. (2012) · PubMed · Cited by 58
The renal microenvironment modifies dendritic cell phenotype
Chessa, F., Mathow, D., Wang, S., Hielscher, T., Atzberger, A., Porubský, Š., Gretz, N., Burgdorf, S., Gröne, H., & Popović, Z. V. (2015) · Kidney International · doi:10.1038/ki.2015.292 · Cited by 46
Molecular cancer cell responses to solid compressive stress and interstitial fluid pressure
Purkayastha, P., Jaiswal, M. K., & Lele, T. P. (2021) · Cytoskeleton · doi:10.1002/cm.21680 · Cited by 50
“Interstitial fluid pressure (IFP) is a marker of malignancy in a number of human cancers (Gutmann et al., 1992; Nathanson & Nelson, 1994).”
Gaiko-Shcherbak, A., Fabris, G., Dreissen, G., Merkel, R., Hoffmann, B., & Noetzel, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145174 · Cited by 46
“interstitial fluid pressure in healthy breast gland tissue and other benign conditions lies in the range of 40 Pa to 53 Pa [50].”
BackgroundWu, C., Hormuth, D. A., Oliver, T., Pineda, F., Lorenzo, G., Karczmar, G. S., Moser, R., & Yankeelov, T. E. (2020) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2020.2975375 · Cited by 46
“For the interstitial fluid pressure, Nathanson and Nelson [19] reported interstitial fluid pressure of (3.”
BackgroundMethodInfluentialRegulation of Tumor Invasion by the Physical Microenvironment: Lessons from Breast and Brain Cancer
Beeghly, G. F., Amofa, K. Y., Fischbach, C., & Kumar, S. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110220-115419 · Cited by 46
“Elevated IFP in human breast tumors compared to adjacent noncancerous tissue was first documented in 1994 for women undergoing biopsy (79).”
BackgroundImproving delivery of antineoplastic agents with anti‐vascular endothelial growth factor therapy
Yang, A. D., Bauer, T. W., Camp, E. R., Somcio, R., Liu, W., Fan, F., & Ellis, L. M. (2005) · Cancer · doi:10.1002/cncr.20942 · Cited by 42
Nathanson, S. D., Nelson, L. T., & Karvelis, K. C. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305661 · Cited by 42
Self-citationLymphangiogenesis and hemangiogenesis: Potential targets for therapy
Witte, M. H., Dellinger, M. T., McDonald, D. M., Nathanson, D. S., Boccardo, F. M., Campisi, C., Sleeman, J. P., & Gershenwald, J. E. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21714 · Cited by 44
“the extent of the increase correlates with the size of the tumor [73].”
BackgroundSentinel Lymph Node Pressure in Breast Cancer
Nathanson, S. D., & Mahan, M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1796-y · Cited by 38
Self-citationThe future of breast cancer: the role of prognostic factors
Gradishar, W. J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-0144-y · Cited by 37
Shiratsuchi, H., & Basson, M. D. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21295 · Cited by 36
Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment
Maekawa, T., Miyake, T., Tani, M., & Üemoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.981547 · Cited by 40
Hofmann, M., McCormack, E., Mujić, M., Roßberg, M., Bernd, A., Bereiter‐Hahn, J., Gjertsen, B. T., Wiig, H., & Kippenberger, S. (2009) · Neoplasia · doi:10.1593/neo.09662 · Cited by 36
“These results are in concert with published data showing that TIFP increases with the tumor volume in other tumor species [28 – 30].”
ResultAkinpelu, A., Akinsipe, T., Avila, L. A., Arnold, R. D., & Mistriotis, P. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10166-x · Cited by 38
“For instance, the relaxation time can range from seconds in the brain, to minutes in the liver, and hours in the skin, with faster stress relaxation indicating increased viscoelasticity [138].”
InfluentialPratt, S. J. P., Lee, R., Chang, K. T., Hernández‐Ochoa, E. O., Annis, D. A., Ory, E. C., Thompson, K. N., Bailey, P. C., Mathias, T. J., Ju, J. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009495117 · Cited by 35
Eichten, A., Hyun, W. C., & Coussens, L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4676 · Cited by 34
Zhang, Q., Jin, H., Chen, L., Chen, Q., He, Y., Yang, Y., Ma, S., Xiao, S., Xi, F., Luo, Q., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00716 · Cited by 32
Dadiani, M., Margalit, R., Sela, N., & Degani, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2665 · Cited by 32
Magdoom, K. N., Pishko, G. L., Rice, L. P., Pampo, C., Siemann, D. W., & Sarntinoranont, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089594 · Cited by 31
Non-invasive imaging of barriers to drug delivery in tumors
Hassid, Y., Eyal, E., Margalit, R., Furman‐Haran, E., & Degani, H. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.06.002 · Cited by 31
Tokuda, S., & Yu, A. S. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143513 · Cited by 32
A numerical framework for interstitial fluid pressure imaging in poroelastic MRE
Tan, L., McGarry, M., Houten, E. E. W. V., Ji, M., Solamen, L. M., Zeng, W., Weaver, J. B., & Paulsen, K. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178521 · Cited by 28
LoCastro, E., Paudyal, R., Mazaheri, Y., Hatzoglou, V., Oh, J. H., Lu, Y., Konar, A. S., Eigen, K. V., Ho, A. L., Ewing, J. R., et al. (2020) · Tomography · doi:10.18383/j.tom.2020.00005 · Cited by 28
Souri, M., Elahi, S., & Soltani, M. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2323211 · Cited by 28
Fovargue, D., Fiorito, M., Capilnasiu, A., Nordsletten, D., Lee, J., & Sinkus, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-62367-3 · Cited by 30
Evaluation of a Voxelized Model Based on DCE-MRI for Tracer Transport in Tumor
Magdoom, K. N., Pishko, G. L., Kim, J. H., & Sarntinoranont, M. (2012) · Journal of Biomechanical Engineering · doi:10.1115/1.4007096 · Cited by 29
Goldson, T. M., Han, Y., Knight, K. B., Weiss, H. L., & Resto, V. A. (2010) · PubMed · Cited by 26
Metadata
- Authors
- Nathanson, S. D., & Nelson, L.
- Affiliations
- Henry Ford Hospital (US)
- Henry Ford Health (US)
- Venue
- Annals of Surgical Oncology
- Published
- 1994-07
- Volume
- 1
- Issue
- 4
- Pages
- 333-338
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2084002680
- Semantic Scholar
- 1bf6086849e3dbcb4b2a549ebf3d364b662f5756
- Cited by
- 197
- References
- 23
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 8 · 2022: 7 · 2021: 11 · 2020: 13 · 2019: 15 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 4 · 2012: 9
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Keywords
- interstitial fluid pressure, breast cancer, invasive ductal carcinoma, benign breast disease, breast parenchyma, tumor size, nonpalpable tumors, tumor localization, stereotactic core needle biopsy, needle aspiration cytology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Biopsy, Needle, Breast Diseases, Breast Neoplasms, Extracellular Space, Female, Humans, Middle Aged, Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.